BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29751876)

  • 1. Recent Advances in the Histopathology of Drug-Induced Liver Injury.
    Kleiner DE
    Surg Pathol Clin; 2018 Jun; 11(2):297-311. PubMed ID: 29751876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
    Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
    Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis.
    Sebode M; Schulz L; Lohse AW
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28895915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis: Liver biopsy differentiates DILI from autoimmune hepatitis.
    Lewis JH
    Nat Rev Gastroenterol Hepatol; 2011 Aug; 8(10):540-2. PubMed ID: 21862981
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe cholestatic hepatitis due to temozolomide: an adverse drug effect to keep in mind. Case report and review of literature.
    Grieco A; Tafuri MA; Biolato M; Diletto B; Di Napoli N; Balducci N; Vecchio FM; Miele L
    Medicine (Baltimore); 2015 Mar; 94(12):e476. PubMed ID: 25816026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced Liver Injury: The Hepatic Pathologist's Approach.
    Kleiner DE
    Gastroenterol Clin North Am; 2017 Jun; 46(2):273-296. PubMed ID: 28506365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide.
    Grant LM; Kleiner DE; Conjeevaram HS; Vuppalanchi R; Lee WM
    Dig Dis Sci; 2013 May; 58(5):1415-21. PubMed ID: 23212393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temozolomide: fatal hepatic failure.
    Prescrire Int; 2014 Sep; 23(152):214. PubMed ID: 25325123
    [No Abstract]   [Full Text] [Related]  

  • 9. Temozolomide induced liver injury.
    Dixit S; Hingorani M; Afzal P; Campbell AP
    Acta Neurol Belg; 2011 Sep; 111(3):249-51. PubMed ID: 22141295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide-induced liver damage. A case report.
    Becker F; Hecht M; Schmidtner J; Semrau S; Fietkau R
    Strahlenther Onkol; 2014 Apr; 190(4):408-10. PubMed ID: 24452817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.
    Suzuki A; Brunt EM; Kleiner DE; Miquel R; Smyrk TC; Andrade RJ; Lucena MI; Castiella A; Lindor K; Björnsson E
    Hepatology; 2011 Sep; 54(3):931-9. PubMed ID: 21674554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Something old, something new: liver injury associated with total parenteral nutrition therapy and immune checkpoint inhibitors.
    Meyerson C; Naini BV
    Hum Pathol; 2020 Feb; 96():39-47. PubMed ID: 31669893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced cholestatic hepatitis: how late can it occur even after the cessation of the culpable drug?
    Zamani N; Mohammad Alizadeh A
    Neuro Oncol; 2012 Jul; 14(7):830. PubMed ID: 22544734
    [No Abstract]   [Full Text] [Related]  

  • 14. Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomide.
    Neyns B; Hoorens A; Stupp R
    Acta Neurol Belg; 2008 Dec; 108(4):131-4. PubMed ID: 19239041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features of drug-induced autoimmune hepatitis and drug-induced liver injury: a comparative analysis].
    Zhao SX; Zhang YG; Tan PF; Wang RQ; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):302-6. PubMed ID: 27470631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced liver injury with autoimmune features complicated with hemophagocytic syndrome.
    Hayashi M; Abe K; Imaizumi H; Okai K; Kanno Y; Takahashi A; Ohira H
    Clin J Gastroenterol; 2016 Jun; 9(3):150-5. PubMed ID: 27076346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathology of drug-induced liver injury.
    Kleiner DE
    Semin Liver Dis; 2009 Nov; 29(4):364-72. PubMed ID: 19826970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system.
    Sarganas G; Orzechowski HD; Klimpel A; Thomae M; Kauffmann W; Herbst H; Bronder E; Garbe E
    Neuro Oncol; 2012 May; 14(5):541-6. PubMed ID: 22394496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute temozolomide induced liver injury : Mixed type hepatocellular and cholestatic toxicity.
    Aygun C; Altınok AY; Çakır A; Agan AF; Balaban Y
    Acta Gastroenterol Belg; 2016; 79(4):487-489. PubMed ID: 28209108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver injury from herbal and dietary supplements.
    Navarro VJ; Khan I; Björnsson E; Seeff LB; Serrano J; Hoofnagle JH
    Hepatology; 2017 Jan; 65(1):363-373. PubMed ID: 27677775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.